Obstetrics and Gynecology International

Complications of Uterine Fibroids and Their Management


Publishing date
15 Dec 2011
Status
Published
Submission deadline
15 Jun 2011

Lead Editor

1Department of Obstetrics and Gynaecology, The University of the West Indies, Mona, Kingston, Jamaica

2Department of Obstetrics and Gynecology, Barking, Havering, and Redbridge University Hospital, Queens Hospital, Romford, Essex RM7 0AG, UK

3University of the West Indies, Mount Hope, St. Augustine, Trinidad

4Rochester General Hospital, 1425 Portland Avenue, Rochester, NY 14621, USA


Complications of Uterine Fibroids and Their Management

Description

Uterine fibroids are the most common gynaecological tumours found in women. These tumours are said to be present in 80% of Caucasian women and are more common in women of African origin. In 50% of women with fibroids, symptoms usually occur, leading to complications from the presence of these fibroids. Although they are mainly a problem in the reproductive years, there are reports of problems from fibroids in postmenopausal women. The management of patients with fibroids can also cause complications for the patient, and, as a result, careful evaluation of patients must be done to decide on the correct treatment option for a particular patient. The focus of this special issue is to highlight the complications which are caused by fibroids and also those which can arise as a result of the treatment options available. This is intended to assist clinicians and their patients in making informed decisions about the management of this common problem. The potential topics to be covered include, but are not limited to:

  • Common symptoms and their management (pain, compression, and hemorrhage)
  • Hematological complications (anaemia, polycythemia, thrombocytosis and thromboembolism) Pregnancy-related complications (infertility, spontaneous abortion, and red degeneration)
  • Sarcomatous change
  • Surgical complications (laparoscopy versus hysterectomy, haemorrhage, and adhesions)
  • Myomectomy versus hysterectomy (vasopressin use versus tourniquet)
  • Hysteroscopic complications
  • Uterine artery embolisation complications

Before submission authors should carefully read over the journal's Author Guidelines, which are located at http://www.hindawi.com/journals/ogi/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/ according to the following timetable:


Articles

  • Special Issue
  • - Volume 2012
  • - Article ID 932436
  • - Editorial

Complications of Uterine Fibroids and Their Management

Horace Fletcher | Celia Burrell | ... | Earlando Thomas
  • Special Issue
  • - Volume 2012
  • - Article ID 943635
  • - Review Article

Innovative Oral Treatments of Uterine Leiomyoma

Mohamed Sabry | Ayman Al-Hendy
  • Special Issue
  • - Volume 2012
  • - Article ID 539365
  • - Review Article

Counselling Patients with Uterine Fibroids: A Review of the Management and Complications

Donnette Simms-Stewart | Horace Fletcher
  • Special Issue
  • - Volume 2012
  • - Article ID 853269
  • - Review Article

Intrauterine Adhesions following Conservative Treatment of Uterine Fibroids

Pietro Gambadauro | Johannes Gudmundsson | Rafael Torrejón
  • Special Issue
  • - Volume 2012
  • - Article ID 290542
  • - Review Article

Complications Associated with Uterine Artery Embolisation for Fibroids

Maria Memtsa | Hayden Homer
  • Special Issue
  • - Volume 2012
  • - Article ID 702325
  • - Research Article

Surgical Management of Uterine Fibroids at Aminu Kano Teaching Hospital

Abiodun Omole-Ohonsi | Francis Belga
  • Special Issue
  • - Volume 2012
  • - Article ID 920831
  • - Clinical Study

Indications and Outcomes of Uterine Artery Embolization in Patients with Uterine Leiomyomas

Hidenori Sasa | Tatsumi Kaji | Kenichi Furuya
  • Special Issue
  • - Volume 2012
  • - Article ID 194839
  • - Review Article

Radiofrequency Ablation for Treatment of Symptomatic Uterine Fibroids

Siân Jones | Peter O'Donovan | David Toub
Obstetrics and Gynecology International
 Journal metrics
Acceptance rate8%
Submission to final decision103 days
Acceptance to publication25 days
CiteScore2.100
Impact Factor-
 Submit

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.